awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38657213-50DE1233-0A7C-4D37-A5C5-19C47ACECFC0
Q38657213-50DE1233-0A7C-4D37-A5C5-19C47ACECFC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38657213-50DE1233-0A7C-4D37-A5C5-19C47ACECFC0
Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care.
P2860
Q38657213-50DE1233-0A7C-4D37-A5C5-19C47ACECFC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38657213-50DE1233-0A7C-4D37-A5C5-19C47ACECFC0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bffe1759f58e9831c51f483bd8f28dad1dee27b9
P2860
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitm